BeyondSpring (BYSI) Interest & Investment Income (2016 - 2026)
BeyondSpring (BYSI) posted Interest & Investment Income of $8000.0 for Q1 2026, down 42.86% sequentially from $14000.0 in Q4 2025, and down 52.94% YoY from $17000.0 in Q1 2025.
BeyondSpring (BYSI) Interest & Investment Income (2016 - 2026) Analysis & Trends
BeyondSpring has reported Interest & Investment Income for 9 years, with the latest figure at $8000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 52.94% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69000.0 (up 46.81% YoY) and the FY2025 annual result came in at $78000.0, up 32.2% from the prior year.
- Interest & Investment Income eased to $8000.0 in Q1 2026 per BYSI's latest filing, from $14000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $29000.0 in Q1 2024 and troughed at $4000.0 in Q4 2024.
- A 3-year average of $16111.1 and a median of $15000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income soared 250.0% in 2025, then sank 52.94% in 2026.
- Over 3 years, Interest & Investment Income stood at $4000.0 in 2024, then jumped by 250.0% to $14000.0 in 2025, then plunged by 42.86% to $8000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $8000.0, $14000.0, and $19000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 28,000.00 |
| Mar 31, 2020 | 64,000.00 |
| Dec 31, 2019 | 120,000.00 |
| Sep 30, 2019 | 57,000.00 |